Alan A Arslan

Author PubWeight™ 78.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009 5.14
2 A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010 4.89
3 Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet 2012 3.69
4 Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 3.51
5 Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol 2009 1.87
6 Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 2010 1.82
7 Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev 2005 1.67
8 Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut 2012 1.66
9 Reproducibility of serum cytokines and growth factors. Cytokine 2008 1.61
10 The diagnosis, treatment, and follow-up of cesarean scar pregnancy. Am J Obstet Gynecol 2012 1.60
11 Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 1.52
12 Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2011 1.44
13 An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One 2013 1.33
14 Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 2004 1.33
15 Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 1.33
16 Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009 1.24
17 Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis 2012 1.20
18 Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control 2012 1.17
19 Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 1.16
20 Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. Eur Cytokine Netw 2009 1.16
21 Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Hum Reprod 2005 1.15
22 Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study. Cancer Causes Control 2010 1.14
23 Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 1.12
24 Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev 2010 1.11
25 Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett 2008 1.09
26 Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int J Cancer 2008 1.08
27 Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control 2010 1.07
28 Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer 2010 1.07
29 HPV vaccine acceptability by Latino parents: a comparison of U.S. and Salvadoran populations. J Pediatr Adolesc Gynecol 2009 1.06
30 Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study. Int J Cancer 2005 1.03
31 Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol 2006 1.01
32 C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy). Cancer Causes Control 2009 0.99
33 Debate preparation/participation: an active, effective learning tool. Teach Learn Med 2008 0.97
34 Defining the genomic signature of the parous breast. BMC Med Genomics 2012 0.97
35 Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecol Oncol 2009 0.96
36 Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study. Breast Cancer Res 2013 0.95
37 Temporal reliability of cytokines and growth factors in EDTA plasma. BMC Res Notes 2010 0.95
38 Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008 0.95
39 Fruits and vegetables and ovarian cancer risk in a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 2005 0.92
40 Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study. Am J Epidemiol 2008 0.92
41 Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. Cancer Epidemiol 2012 0.92
42 Characterization of a genomic signature of pregnancy identified in the breast. Cancer Prev Res (Phila) 2011 0.89
43 Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis 2011 0.89
44 Factors associated with inflammation markers, a cross-sectional analysis. Cytokine 2011 0.89
45 Reliability of serum assays of iron status in postmenopausal women. Ann Epidemiol 2006 0.89
46 Premenopausal serum androgens and breast cancer risk: a nested case-control study. Breast Cancer Res 2012 0.89
47 The effect of consolidation of abortion services on patient outcomes. Contraception 2007 0.87
48 Global breast cancer: the lessons to bring home. Int J Breast Cancer 2011 0.86
49 Genetic variants in hormone-related genes and risk of breast cancer. PLoS One 2013 0.85
50 Insulin-like growth factor I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006 0.84
51 Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome. Am J Obstet Gynecol 2011 0.82
52 Qualified and trained sonographers in the US can perform early fetal anatomy scans between 11 and 14 weeks. Am J Obstet Gynecol 2004 0.81
53 Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes Control 2013 0.81
54 Re: C-reactive protein and risk of breast cancer. J Natl Cancer Inst 2008 0.80
55 Circulating enterolactone and risk of endometrial cancer. Int J Cancer 2006 0.80
56 Spherical tissue sampling in 3-dimensional power Doppler angiography: a new approach for evaluation of ovarian tumors. J Ultrasound Med 2008 0.79
57 Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes Control 2013 0.78
58 Maternal and neonatal outcomes in early glucose tolerance testing in an obstetric population in New York city. J Perinat Med 2009 0.78
59 Re: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011 0.78
60 Predictors of severe perineal lacerations in Chinese women. J Perinat Med 2009 0.77
61 Two hundred ninety consecutive cases of multifetal pregnancy reduction: comparison of the transabdominal versus the transvaginal approach. Am J Obstet Gynecol 2004 0.77
62 Re: Letter to the editor on "Bias in clinical intervention research". Am J Epidemiol 2007 0.75
63 Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. PLoS One 2015 0.75
64 Parallel maternal and fetal immune activation by bacterial toxins in vitro. J Perinat Med 2011 0.75
65 Extra-amniotic saline infusion increases cesarean risk versus other induction methods and spontaneous labor. Am J Perinatol 2006 0.75
66 Analysis of circulating annexin A5 parameters during pregnancy: absence of differences between women with recurrent spontaneous pregnancy losses and controls. Am J Obstet Gynecol 2006 0.75